Long-term excretion of vaccine-derived poliovirus by a healthy child
- PMID: 15564492
- PMCID: PMC533926
- DOI: 10.1128/JVI.78.24.13839-13847.2004
Long-term excretion of vaccine-derived poliovirus by a healthy child
Abstract
A child was found to be excreting type 1 vaccine-derived poliovirus (VDPV) with a 1.1% sequence drift from Sabin type 1 vaccine strain in the VP1 coding region 6 months after he was immunized with oral live polio vaccine. Seventeen type 1 poliovirus isolates were recovered from stools taken from this child during the following 4 months. Contrary to expectation, the child was not deficient in humoral immunity and showed high levels of serum neutralization against poliovirus. Selected virus isolates were characterized in terms of their antigenic properties, virulence in transgenic mice, sensitivity for growth at high temperatures, and differences in nucleotide sequence from the Sabin type 1 strain. The VDPV isolates showed mutations at key nucleotide positions that correlated with the observed reversion to biological properties typical of wild polioviruses. A number of capsid mutations mapped at known antigenic sites leading to changes in the viral antigenic structure. Estimates of sequence evolution based on the accumulation of nucleotide changes in the VP1 coding region detected a "defective" molecular clock running at an apparent faster speed of 2.05% nucleotide changes per year versus 1% shown in previous studies. Remarkably, when compared to several type 1 VDPV strains of different origins, isolates from this child showed a much higher proportion of nonsynonymous versus synonymous nucleotide changes in the capsid coding region. This anomaly could explain the high VP1 sequence drift found and the ability of these virus strains to replicate in the gut for a longer period than expected.
Figures

Similar articles
-
Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.J Appl Microbiol. 2006 Dec;101(6):1367-79. doi: 10.1111/j.1365-2672.2006.03020.x. J Appl Microbiol. 2006. PMID: 17105568
-
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26468545 Free PMC article.
-
Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.Virus Res. 2007 Jul;127(1):17-25. doi: 10.1016/j.virusres.2007.03.009. Epub 2007 Apr 20. Virus Res. 2007. PMID: 17449127
-
Vaccine-derived poliovirus from long term excretors and the end game of polio eradication.Biologicals. 2006 Jun;34(2):117-22. doi: 10.1016/j.biologicals.2006.02.005. Epub 2006 May 2. Biologicals. 2006. PMID: 16650772 Review.
-
Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.Acta Virol. 1996 Jun;40(3):157-70. Acta Virol. 1996. PMID: 8891097 Review.
Cited by
-
Lessons from the eradication of smallpox: an interview with D. A. Henderson.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20130113. doi: 10.1098/rstb.2013.0113. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798700 Free PMC article.
-
Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.Future Microbiol. 2010 Sep;5(9):1329-47. doi: 10.2217/fmb.10.101. Future Microbiol. 2010. PMID: 20860480 Free PMC article. Review.
-
New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.Clin Infect Dis. 2008 Dec 15;47(12):1587-92. doi: 10.1086/593310. Clin Infect Dis. 2008. PMID: 18990066 Free PMC article. Review.
-
Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.J Virol. 2008 Sep;82(17):8927-32. doi: 10.1128/JVI.00239-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579607 Free PMC article.
-
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.J Virol. 2009 Sep;83(17):8693-704. doi: 10.1128/JVI.02388-08. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515771 Free PMC article.
References
-
- Abo, W., S. Chiba, T. Yamanaka, T. Nakao, M. Hara, and I. Tagaya. 1979. Paralytic poliomyelitis in a child with agammaglobulinemia. Eur. J. Pediatr. 132:11-16. - PubMed
-
- Alexander, J. P., Jr., H. E. Gary, Jr., and M. A. Pallansch. 1997. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis. 175(Suppl. 1):S176-S182. - PubMed
-
- Anonymous. 2001. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus—Philippines, 2001. Morb. Mortal. Wkly. Rep. 50:874-875. - PubMed
-
- Bellmunt, A., G. May, R. Zell, P. Pring-Akerblom, W. Verhagen, and A. Heim. 1999. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265:178-184. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical